PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 20 2024
0mins
Source: Businesswire
Investigation of Poseida Therapeutics Sale: Halper Sadeh LLC is investigating the fairness of Poseida Therapeutics' sale to Roche Holdings for $9.00 per share, plus contingent payments, focusing on potential violations of federal securities laws and fiduciary duties by Poseida's board.
Legal Rights for Shareholders: The law firm encourages Poseida shareholders to explore their legal rights regarding the transaction, which may include seeking increased compensation or additional disclosures about the merger.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
